Andes Biotechnologies Company

Andes Biotechnologies is a leading nucleic acid-based drug discovery and development company focused on solid tumor cancers. The Company has discovered two novel families of long non-coding RNAs: sense (S-RNA) and antisense (AS-RNA). Both are present in all human cells, are synthesized in the mitochondria and migrate to the nucleus.
Technology: Apps & Platforms
Industry: Genomic and Epigenominc Instabillity
Headquarters: Chile
Founded Date: 2008
Estimated Revenue: $1M to $10M

Visit Website
Register and Claim Ownership